share_log

Percheron Therapeutics Ltd: Phase IIb study of ATL1102 in DMD completes recruitment

May 29 07:01
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more